Can the heart shrink in dilated cardiomyopathy with long-term medication?

　　Dilated cardiomyopathy (DCM) generally refers to a condition in which the heart becomes enlarged. In general, after long-term medication, the heart may shrink in some patients with dilated cardiomyopathy, but it may not shrink in others. The specific analysis is as follows:

　　1. Yes, the heart may shrink

　　For patients diagnosed early and receiving active treatment for dilated cardiomyopathy, if there are no complications such as heart failure or malignant arrhythmias, regular long-term drug therapy under medical supervision—such as enalapril maleate, irbesartan tablets, and metoprolol tartrate tablets—can relieve symptoms in most patients and lead to a reduction in the size of the enlarged heart. Therefore, there is indeed a possibility of the heart shrinking.

　　2. No, the heart may not shrink

　　The main features of dilated cardiomyopathy include an enlarged cardiac boundary, ventricular dilation, and thinning of the ventricular wall. Drug therapy can only prevent progressive cardiac enlargement, delay ventricular remodeling and further myocardial damage, and slow disease progression. Therefore, after drug treatment, the heart may not actually decrease in size.

　　In summary, whether long-term medication can reduce heart size in patients with dilated cardiomyopathy depends on individual circumstances. However, regardless of outcome, timely medical evaluation and adherence to prescribed medications under a doctor's guidance are essential to control disease progression.